Opko Health Inc. announced new compensation terms for its executive officers following a meeting of the company's Compensation Committee on May 27, 2025. The company granted stock options and approved bonus payments for its top executives. Phillip Frost, M.D., the CEO and Chairman, received 500,000 stock options with an exercise price of $1.31 per share and a bonus of $480,000. Vice Chairman and Chief Technical Officer, Jane H. Hsiao, Ph.D., and Vice Chairman and President, Elias A. Zerhouni, M.D., each received 500,000 stock options and a bonus of $450,000. Executive Vice President Steven D. Rubin was awarded 437,500 stock options and a $400,000 bonus, while Senior Vice President and CFO Adam Logal received the same number of stock options and a $475,000 bonus. The options vest annually over four years and expire ten years from the grant date.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.